Our laboratory actively promotes industry–academia collaboration.
If you are interested in developing innovative diagnostics and therapeutics centered on extracellular vesicles (EVs/exosomes), we would be delighted to hear from you.
(Contact: Yu Fujita — yuugot@jikei.ac.jp)
If you are interested in developing innovative diagnostics and therapeutics centered on extracellular vesicles (EVs/exosomes), we would be delighted to hear from you.
(Contact: Yu Fujita — yuugot@jikei.ac.jp)
EV-Based Drug Development (Therapeutic EV Products)
- Development of Airway Epithelial Cell–Derived EV Therapeutics
- Development of Engineered EV Therapeutics
- Establishment of EV Drug Product Manufacturing Processes in Collaboration with Multiple Industry Partners
- Building an EV Manufacturing Platform and Related Industry Consortium
Establishing Quality Standards and Safety Evaluation for EV Therapeutics
- Quality Specifications for EV Drug Products
- Safety Assessment Across EV Manufacturing Processes
- Establishing Novel Analytical Methods for EV Quality
EV-Based Liquid Biopsy & Drug Delivery (DDS)
- Liquid-Biopsy Collaborations for Cancer & Infectious Diseases with Global Pharma, Japanese Startups, and AI Firms
- Development of an EV-Based Early Detection Assay for Pancreatic Cancer
- EV-Based Vaccine Development
- Applications of EV-Based Drug Delivery Systems (DDS)
Research on Next-Generation Health Screening Using AI-Assisted Chest X-ray Diagnostics
- Study on Reading-Workflow Efficiency Gains from Chest X-ray AI Assistance
- Research on Next-Generation Comprehensive Checkups Using Chest X-ray AI
Pathomechanistic Research in Intractable Diseases
- Single-Cell, Spatial, and EV Analyses in Nationwide Academic Collaborations
- Basic and Translational Research Across Oncology, Respiratory, Gastroenterology, and Infectious Diseases
- Senolytic-Based Therapies for Age-Related Pathologies (International Collaboration)